Even if you believe that the recent news coverage on the price of cancer drugs was abysmally incomplete, you have to feel a measure of sympathy for the news producers. It’s difficult – in fact, virtually impossible – to explain a subject as complex as healthcare and the intricacies of pricing medical goods and services in a 15-minute segment. Knowing that comprehensive clarity was not doable, the report went for ratings. That’s the nature of the business.
Read Full Article »
